“Black Box” Gives Black Eye To Prospects For COX-2 Ads Returning
This article was originally published in The Tan Sheet
Executive Summary
While an FDA advisory committee voted strongly in favor of allowing continued marketing of Celebrex (celecoxib), the panel's recommendations for warnings diminish the prospects of renewed DTC marketing